Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cerebrovascular Accident in a Child With Precursor B-Cell Acute Lymphoblastic Leukemia and Coronavirus Disease 2019: A Case Report Publisher Pubmed



Karimi H1 ; Sarmadian R2 ; Gilani A3 ; Salajegheh P4 ; Nejad Biglari H5 ; Gholizadeh M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Alumna of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Infectious Disease, Arak University of Medical Sciences, Arak, Iran
  3. 3. Department of Pediatric Surgery, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Pediatric Oncology, Kerman University of Medical Sciences, Kerman, Iran
  5. 5. Department of Pediatric Neurology, Kerman University of Medical Sciences, Kerman, Iran

Source: Journal of Medical Case Reports Published:2022


Abstract

Background: Coronavirus disease 2019 can lead to rare but severe and life-threatening diseases in susceptible high-risk populations, including patients with immunodeficiency. A rare event in this report is stroke following COVID-19 disease in a patient with an immunocompromised background due to leukemia and anti-cancer treatments. Case presentation: A 6-year-old iranian girl with precursor B-cell leukemia receiving vincristine therapy presented with fever and absolute neutrophil count < 500. Her severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test was positive. During hospitalization, she had abrupt onset tachypnea, reduced O2 saturation, and generalized tonic–clonic seizures treated with phenytoin and levetiracetam. Right parietal lobe ischemia was found on a brain computed tomography scan, and the cerebrospinal fluid polymerase chain reaction test was positive for severe acute respiratory syndrome coronavirus 2. Several days later, she developed lower extremity paralysis and speech impairment, so speech therapy and physiotherapy were initiated. The patient also received dexamethasone, mannitol, heparin, and remdesivir. She was discharged with enoxaparin and levetiracetam. Chemotherapy resumed 2 weeks following discharge. Her speech and walking improved after 10 months of follow-up, and bone marrow aspiration showed total remission. Conclusion: Owing to the link between coronavirus disease 2019 and hematologic cancers with hypercoagulopathy and the tendency of patients with leukemia to have coronavirus disease 2019 complications, children with leukemia as well as suspected coronavirus disease 2019 must be hospitalized to prevent blood clot formation. © 2022, The Author(s).
Other Related Docs
30. Febuxostat Therapy in Outpatients With Suspected Covid-19: A Clinical Trial, International Journal of Clinical Practice (2020)
39. What Is the Best Treatment Option for Head and Neck Cancers in Covid-19 Pandemic? a Rapid Review, American Journal of Otolaryngology - Head and Neck Medicine and Surgery (2020)
42. Sars-Cov-2 Infection in Cancer Patients, Susceptibility, Outcome and Care, American Journal of the Medical Sciences (2022)
49. A Review on Hematologic Malignant Patients Infected With 2019 Novel Coronavirus, Archives of Clinical Infectious Diseases (2020)